Marja Steenman
University of Amsterdam
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marja Steenman.
European Journal of Human Genetics | 1994
Marcel Mannens; Jan M. N. Hoovers; Egbert J. W. Redeker; Verjaal M; Andrew P. Feinberg; P.F.R. Little; Boavida M; Coad N; Marja Steenman; Jet Bliek
Cytogenetic and DNA analyses of patients with the Beckwith-Wiedemann syndrome (BWS) enabled us to refine the localization of the syndrome at 11p15.3-pter to two distinct regions. One chromosome region (BWSCR1) is near the insulin (INS) and insulin-like growth factor 2 (IGF2) genes. The other region (BWSCR2) is more proximal near two sequences with zinc-binding finger motifs and a number of known and putative genes. This latter region, at least, seems to be associated with the development of childhood tumors. Our results strongly support the proposed involvement of parental imprinting in the etiology of BWS since all balanced chromosomal abnormalities in these patients were maternally transmitted while the mothers were phenotypically normal. We demonstrate that such an autosomal balanced rearrangement can lead to a specific maternal hypomethylation of the INS/IGF2 genes localized distal to the breakpoint. This underlines the role of these genes in the etiology of the syndrome.
Cytogenetic and Genome Research | 1997
Marja Steenman; Bert Redeker; M. de Meulemeester; K. Wiesmeijer; P.A. Voûte; Andries Westerveld; Rosalyn Slater; Marcel Mannens
In this study we have applied the technique of comparative genomic hybridization (CGH) to a large series of sporadic Wilms tumors, including six samples of the associated nephroblastomatosis. The data obtained were compared with the findings of molecular studies carried out on the same material. The aims of the study were (1) to characterize the range of genetic variation in sporadic Wilms tumor and nephroblastomatosis, (2) to determine whether changes could be found that have not been detected by commonly used techniques, and (3) to compare the sensitivity of CGH with that of conventional molecular analysis. The chromosomes that showed gains and losses by CGH were similar to those previously found in molecular and cytogenetic studies, however loss of 4q was a new event identified in 2 out of 46 tumors. We did not detect amplified genetic material. Comparison of the data from the nephroblastomatosis and tumor samples from the same patient showed that loss of 7p may be associated with malignant transformation, and that losses in 1p, 11p, 4q and gains in 1q and 12q can be early events; whilst loss in 9p and gain of 8, 10q and 18 are possible secondary changes in tumor development. The combined CGH and molecular techniques used demonstrated involvement of two specific 1p regions in the etiology of Wilms tumor.
Cytogenetic and Genome Research | 1999
Marja Steenman; G. Tomlinson; Andries Westerveld; Marcel Mannens
We applied the technique of comparative genomic hybridization (CGH) to a series of 16 hepatoblastomas. Our goals were (1) to identify all quantitative chromosome abnormalities that appear in this type of tumor and (2) to compare the results with data from similar studies on other tumors associated with the Beckwith-Wiedemann syndrome (BWS). We found that the most commonly detected (> 30%) chromosome abnormalities were gains of chromosomes 1, 2, 7, 8, and 17. Losses of chromosomes were found in only a few cases. On comparing our results with those from studies on the BWS-associated tumors, Wilms tumor and rhabdomyosarcoma, it became clear that three chromosome regions, namely, 7q, 8q, and 17q, were the ones most commonly involved in all three types of tumors. These regions, therefore, may harbor genes that play a role in the etiology of BWS-associated tumors in general.
Genetic Analysis: Biomolecular Engineering | 1996
Maurice de Meulemeester; Agnes Vinka; Marja E. Jakobs; Mario Hermsen; Marja Steenman; Rosalyn Slates; Axel J. J. Dietrich; Marcel Mannensa
Comparative genomic hybridization (CGH) is a powerful tool for analyzing unbalanced chromosomal rearrangements in a variety of tissues. However, reproducibility of the technique is poor. We have developed an alternative protocol involving microwave denaturation of the metaphase chromosome preparations prior to the hybridization step. The advantage of this method for CGH is the retention of the morphology of the chromosomes and hence an improved chromosome banding pattern. Furthermore, it results in a consistently strong hybridization which is not dependent on the batch of lymphocytes used to obtain the metaphase chromosome spreads. This procedure has also proved to be applicable to nucleic acid hybridizations in general. The protocol, its application and the results of this method in CGH is discussed. Furthermore preliminary results of this method in paint and DNA probe hybridizations to chromosome spreads and to RNA in tissue sections are presented.
Cytogenetic and Genome Research | 2000
Marja Steenman; N. Zijlstra; Danny L Kruitbosch; C.C. Wiesmeijer; L. Larizza; P.A. Voûte; Andries Westerveld; Marcel Mannens
Sporadic childhood tumors associated with Beckwith-Wiedemann syndrome (BWS) all show abnormalities of the same region on chromosome 11. In addition to chromosome 11, other chromosome regions are affected in some of these tumor types. In this study we analyzed the region on chromosome 1p involved in the etiology of BWS-associated tumors, Wilms tumor, rhabdomyosarcoma, and hepatoblastoma. For this purpose we determined the location of two novel translocation breakpoints in this chromosome region in cells from a Wilms tumor and cells from a rhabdomyosarcoma. We constructed a map of the region and found that both breakpoints are separated by at least 875 kb. We identified a PAC clone which crosses the rhabdomyosarcoma breakpoint and found several exons within this clone. We established that this breakpoint is located proximal to the PAX7 gene and, therefore, identified a new region involved in the etiology of rhabdomyosarcomas.
Cancer Genetics and Cytogenetics | 1996
Marja Steenman; M. de Meulemeester; C. Wiesmeijer; E. Redeker; Andries Westerveld; P.A. Voûte; Rosalyn Slater; Marcel Mannens
In this study we have applied the technique of comparative genomic hybridization (CGH) to a large series of sporadic Wilms tumors, including six samples of the associated nephroblastomatosis. The data obtained were compared with the findings of molecular studies carried out on the same material. The aims of the study were (1) to characterize the range of genetic variation in sporadic Wilms tumor and nephroblastomatosis, (2) to determine whether changes could be found that have not been detected by commonly used techniques, and (3) to compare the sensitivity of CGH with that of conventional molecular analysis. The chromosomes that showed gains and losses by CGH were similar to those previously found in molecular and cytogenetic studies, however loss of 4q was a new event identified in 2 out of 46 tumors. We did not detect amplified genetic material. Comparison of the data from the nephroblastomatosis and tumor samples from the same patient showed that loss of 7p may be associated with malignant transformation, and that losses in 1p, 11p, 4q and gains in 1q and 12q can be early events; whilst loss in 9p and gain of 8, 10q and 18 are possible secondary changes in tumor development. The combined CGH and molecular techniques used demonstrated involvement of two specific 1p regions in the etiology of Wilms tumor.
Nature Genetics | 1994
Marja Steenman; Shirley Rainier; Craig J. Dobry; Paul E. Grundy; Isabelle L. Horon; Andrew P. Feinberg
Proceedings of the National Academy of Sciences of the United States of America | 1995
Jan M. N. Hoovers; Linda M. Kalikin; Laura A. Johnson; Marielle Alders; Bert Redeker; David J. Law; Jet Bliek; Marja Steenman; Mary A. Benedict; J. Wiegant; Christoph Lengauer; Patti Taillon-Miller; David Schlessinger; Michael C. Edwards; Stephen J. Elledge; Al Ivens; Andries Westerveld; Peter Little; Marcel Mannens; Andrew P. Feinberg
Genes, Chromosomes and Cancer | 2000
Marja Steenman; Andries Westerveld; Marcel Mannens
Medical and Pediatric Oncology | 1996
Marcel Mannens; Marielle Alders; Bert Redeker; Jet Bliek; Marja Steenman; Carien Wiesmeyer; Maurice de Meulemeester; Andy Ryan; Linda M. Kalikin; Tom Voûte; Jan de Kraker; Jan M. N. Hoovers; Rosalyn Slater; Andrew P. Feinberg; Peter Little; Andries Westerveld